Inventor
KASTELEIN JOHN
NL5 patents
⚠️ This page may combine multiple inventors who share the name “KASTELEIN JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DEZIMA PHARMA B V
3 patentsUS10300059B2May 28, 2019
Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and HMG CoA reductase inhibitors
DEZIMA PHARMA B V11 citations81
US11013742B2May 25, 2021
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
DEZIMA PHARMA B V6 citations80
US10653692B2May 19, 2020
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
DEZIMA PHARMA B V6 citations80
NEWAMSTERDAM PHARMA B V
2 patentsUS11642344B2May 9, 2023
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
NEWAMSTERDAM PHARMA B V5 citations82
US12186315B2Jan 7, 2025
Cholesteryl ester transfer protein (CETP) inhibitor and pharmaceutical compositions comprising said inhibitor for use in the treatment or prevention of cardiovascular diseases
NEWAMSTERDAM PHARMA B V0 citations59